Last updated on August 2008

Juvenile Idiopathic Arthritis (JIA) - Minors


Brief description of study

Juvenile Idiopathic Arthritis (JIA) - Minors

Detailed Study Description

Parents with children with Juvenile Idiopathic Arthritis (JIA) are asked to participate in a research study being conducted by Schneider Children's Hospital.

Patient Inclusion Criteria
Your child may be eligible to participate in this study if your child:

  • Is 4 to 17 years old
  • Has been diagnosed with JIA
  • Is taking Humira® or MTX therapy

Patient Exclusion Criteria
Your child may not participate in this study if your child:

  • Cannot be treated with Humira®
  • Has been treated with any approved or experimental drug such as etanercept (Enbrel®), abatacept (Orencia®), infliximab (Remicade®) or rituximab (Rituxan®).
  • Has participated in another research study within the last 30 days.

Clinical Study Identifier: TX134394

Contact Investigators or Research Sites near you

Start Over

Marilynn Orlando

Biomedical Research Alliance of New York
New Hyde Park, NY USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.